Antiplatelet drug

Results: 154



#Item
1Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer

Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer

Add to Reading List

Source URL: www.diapin.com

Language: English - Date: 2015-03-10 10:24:06
2clopidogrel vs indocin credo clopidogrel exclusion criteria. clopidogrel acuphase high dose clopidogrel ticlopidine clopidogrel and cyclosporine a, indications for clopidogrel. clopidogrel actions. omeprazole and clopido

clopidogrel vs indocin credo clopidogrel exclusion criteria. clopidogrel acuphase high dose clopidogrel ticlopidine clopidogrel and cyclosporine a, indications for clopidogrel. clopidogrel actions. omeprazole and clopido

Add to Reading List

Source URL: observantnomad.com

Language: English - Date: 2016-08-20 11:37:03
3Antiplatelet drugs / Cilostazol / Lactams / Quinolones / Tetrazoles / Vasodilators / Angiogenesis / Duchenne muscular dystrophy

Research Review NoA new drug to look out for. The Studies:

Add to Reading List

Source URL: www.actionduchenne.org

Language: English - Date: 2016-02-23 08:26:48
4Supplementary Material to Beyer-Westendorf et al. “Effectiveness and  safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry” (Thromb Haemost 2015; 113.6)

Supplementary Material to Beyer-Westendorf et al. “Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry” (Thromb Haemost 2015; 113.6)

Add to Reading List

Source URL: th.schattauer.de

Language: English - Date: 2015-03-05 03:09:54
5Microsoft Word - ANTIPLATELET DRUG COMPARISON CHART.doc

Microsoft Word - ANTIPLATELET DRUG COMPARISON CHART.doc

Add to Reading List

Source URL: www.vhpharmsci.com

Language: English - Date: 2012-10-30 16:26:23
    6DKF Research Conference Langhans Hörsaal Pathologie Murtenstrasse 31, 3010 Bern Date

    DKF Research Conference Langhans Hörsaal Pathologie Murtenstrasse 31, 3010 Bern Date

    Add to Reading List

    Source URL: www.dkf.unibe.ch

    Language: English - Date: 2015-04-28 08:55:45
    7Lack of Drug-Drug Interactions with M118, a Novel, Rationally Engineered Low Molecular Weight Heparin, When Co-Administered with Multiple Doses of Aspirin and Clopidogrel

    Lack of Drug-Drug Interactions with M118, a Novel, Rationally Engineered Low Molecular Weight Heparin, When Co-Administered with Multiple Doses of Aspirin and Clopidogrel

    Add to Reading List

    Source URL: www.momentapharma.com

    Language: English - Date: 2012-06-27 15:00:39
    8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. ®

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTEGRILIN safely and effectively. See full prescribing information for INTEGRILIN. ®

    Add to Reading List

    Source URL: www.merck.com

    Language: English - Date: 2015-03-26 19:23:33
    9CLINICAL  Dual antiplatelet therapy Management in general practice Rohan Jayasinghe Ryan Markham

    CLINICAL Dual antiplatelet therapy Management in general practice Rohan Jayasinghe Ryan Markham

    Add to Reading List

    Source URL: www.racgp.org.au

    Language: English - Date: 2013-09-26 00:20:13
    10Carotid ENDARTERECTOMY  provision of information SYMPTOMATIC CAROTID ARTERY DISEASE

    Carotid ENDARTERECTOMY provision of information SYMPTOMATIC CAROTID ARTERY DISEASE

    Add to Reading List

    Source URL: www.sign.ac.uk

    Language: English - Date: 2014-05-12 05:10:06